Bharat Serums Has Potential To Become a ₹4,000 to ₹5,000 Cr Company: Mankind Pharma To NDTV Profit

Описание к видео Bharat Serums Has Potential To Become a ₹4,000 to ₹5,000 Cr Company: Mankind Pharma To NDTV Profit

Mankind Pharma's Vice Chairman and MD, Rajeev Juneja, discussed their strategic acquisition of Bharat Serum & Vaccines, focusing on its high-entry barrier products and growth potential in specialized areas like fertility.

#mankindpharma #bsv #acquisitions

For more videos subscribe to our channel:    / @ndtvprofitindia  
Visit NDTV Profit for more news: https://www.ndtvprofit.com/
Don't enter the stock market unaware. Read all Research Reports here: https://www.ndtvprofit.com/research-r...

Follow NDTV Profit here
Twitter:   / ndtvprofitindia   ,   / ndtvprofit  
LinkedIn:   / ndtvprofit  
Instagram:   / ndtvprofit  
Facebook:   / ndtvprofit  

Комментарии

Информация по комментариям в разработке

Похожие видео